UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A systematic review of the pathophysiology of 5-fluorouracil-induced cardiotoxicity

BMC pharmacology & toxicology, 2014-09, Vol.15 (1), p.47-47, Article 47

2014

Volltextzugriff (PDF)

miR-345 in metastatic colorectal cancer: a non-invasive biomarker for clinical outcome in non-KRAS mutant patients treated with 3rd line cetuximab and irinotecan

PloS one, 2014-06, Vol.9 (6), p.e99886-e99886

2014

Volltextzugriff (PDF)

Efficacy of HER2-targeted therapy in metastatic breast cancer. Monoclonal antibodies and tyrosine kinase inhibitors

Breast (Edinburgh), 2013-02, Vol.22 (1), p.1-12

2013

Volltextzugriff (PDF)

Plasma YKL-40 is associated with prognosis in patients with metastatic pancreatic cancer receiving immune checkpoint inhibitors in combination with radiotherapy

Frontiers in immunology, 2023-09, Vol.14, p.1228907-1228907

2023

Volltextzugriff (PDF)

Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: A systematic review of incidence, manifestations and predisposing factors

Cancer treatment reviews, 2013-12, Vol.39 (8), p.974-984

2013

Volltextzugriff (PDF)

Pre-existing TGF-β-specific T-cell immunity in patients with pancreatic cancer predicts survival after checkpoint inhibitors combined with radiotherapy

Journal for immunotherapy of cancer, 2023-03, Vol.11 (3), p.e006432

2023

Volltextzugriff (PDF)

Development and validation of circulating protein signatures as diagnostic biomarkers for biliary tract cancer

JHEP reports, 2023-03, Vol.5 (3), p.100648-100648, Article 100648

2023

Volltextzugriff (PDF)

Gemcitabine Plus Docetaxel Versus Docetaxel in Patients With Predominantly Human Epidermal Growth Factor Receptor 2–Negative Locally Advanced or Metastatic Breast Cancer: A Randomized, Phase III Study by the Danish Breast Cancer Cooperative Group

Journal of clinical oncology, 2011-12, Vol.29 (36), p.4748-4754

2011

Volltextzugriff (PDF)

Effects of a 12-Week Multimodal Exercise Intervention Among Older Patients with Advanced Cancer: Results from a Randomized Controlled Trial

The oncologist (Dayton, Ohio), 2022-02, Vol.27 (1), p.67-78

2022

Volltextzugriff (PDF)

TIMP-1 and responsiveness to gemcitabine in advanced breast cancer; results from a randomized phase III trial from the Danish breast cancer cooperative group

BMC cancer, 2014-05, Vol.14 (1), p.360-360, Article 360

2014

Volltextzugriff (PDF)

Metabolomic NMR Fingerprinting to Identify and Predict Survival of Patients with Metastatic Colorectal Cancer

Cancer research (Chicago, Ill.), 2012, Vol.72 (1), p.356-364

2012

Volltextzugriff (PDF)

Adjuvant Cyclophosphamide and Docetaxel With or Without Epirubicin for Early TOP2A-Normal Breast Cancer: DBCG 07-READ, an Open-Label, Phase III, Randomized Trial

Journal of clinical oncology, 2017-08, Vol.35 (23), p.2639-2646

2017

Volltextzugriff (PDF)

Circulating Protein Biomarkers for Use in Pancreatic Ductal Adenocarcinoma Identification

Clinical cancer research, 2021-05, Vol.27 (9), p.2592-2603

2021

Volltextzugriff (PDF)

Physical decline, falls, and hospitalization among vulnerable older patients in the trajectory of colorectal cancer treatment

Journal of geriatric oncology, 2024-09, Vol.15 (7), p.101820, Article 101820

2024

Volltextzugriff (PDF)

Nurse-Led Individualized Follow-Up Versus Regular Physician-Led Visits After Early Breast Cancer (MyHealth): A Phase III Randomized, Controlled Trial

Journal of clinical oncology, 2024-06

2024

Volltextzugriff (PDF)

Prognostic Value of Pretreatment Plasma C-Reactive Protein in Patients with Early-Stage Breast Cancer

Cancer epidemiology, biomarkers & prevention, 2024-05, Vol.33 (5), p.662-670

2024

Volltextzugriff (PDF)

A systematic review on topoisomerase 1 inhibition in the treatment of metastatic breast cancer

Breast cancer research and treatment, 2013-04, Vol.138 (2), p.347-358

2013

Volltextzugriff (PDF)

Cetuximab plus irinotecan administered biweekly with reduced infusion time to heavily pretreated patients with metastatic colorectal cancer and related RAS and BRAF mutation status

International journal of cancer, 2021-05, Vol.148 (10), p.2542-2556

2021

Volltextzugriff (PDF)

Therapy with pembrolizumab in treatment‐naïve patients with nonmetastatic, mismatch repair deficient colorectal cancer

International journal of cancer, 2023-05, Vol.152 (10), p.2145-2152

2023

Volltextzugriff (PDF)

Myocardial Ischemia Induced by 5‐Fluorouracil: A Prospective Electrocardiographic and Cardiac Biomarker Study

The oncologist (Dayton, Ohio), 2021-03, Vol.26 (3), p.e403-e413

2021

Volltextzugriff (PDF)

Antitumour immunity invoked by hepatic arterial infusion of first‐line oxaliplatin predicts durable colorectal cancer control after liver metastasis ablation: 8–12 years of follow‐up

International journal of cancer, 2020-04, Vol.146 (7), p.2019-2026

2020

Volltextzugriff (PDF)

Tissue-Doppler Assessment of Cardiac Left Ventricular Function during Short-Term Adjuvant Epirubicin Therapy for Breast Cancer

Journal of the American Society of Echocardiography, 2011-02, Vol.24 (2), p.200-206

2011

Volltextzugriff (PDF)

Similar Efficacy for Ovarian Ablation Compared With Cyclophosphamide, Methotrexate, and Fluorouracil: From a Randomized Comparison of Premenopausal Patients With Node-Positive, Hormone Receptor–Positive Breast Cancer

Journal of clinical oncology, 2006-11, Vol.24 (31), p.4956-4962

2006

Volltextzugriff (PDF)

Cancer patients, physicians, and nurses differ in their attitudes toward the decisional role in do-not-resuscitate decision-making

Supportive care in cancer, 2020-12, Vol.28 (12), p.6057-6066

2020

Volltextzugriff (PDF)

Preoperative plasma vitamin D in patients with localized colorectal cancer: Age-dependent association with inflammation, postoperative complications, and survival

European journal of surgical oncology, 2023-01, Vol.49 (1), p.244-251

2023

Volltextzugriff (PDF)

1 – 25 von 197

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(179)
Mit Volltextzugriff
(160)

Publikationsform

Sprache

Englisch
(186)
Dänisch
(12)

Erscheinungsjahr

n.n

Thema

Science & Technology
(149)
Life Sciences & Biomedicine
(140)
Humans
(113)
Female
(85)
Oncology
(51)
Male
(48)
Adult
(47)
Aged
(45)
Middle Aged
(44)
Biological And Medical Sciences
(38)
Medical Sciences
(32)
Breast Neoplasms - Drug Therapy
(21)
Treatment Outcome
(21)
Animals
(20)
Aged, 80 And Over
(18)
Risk Factors
(18)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(17)
Cancer
(16)
Denmark
(16)
Chemotherapy
(15)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A systematic review of the pathophysiology of 5-fluorouracil-induced cardiotoxicity

miR-345 in metastatic colorectal cancer: a non-invasive biomarker for clinical outcome in non-KRAS mutant patients treated with 3rd line cetuximab and irinotecan

Efficacy of HER2-targeted therapy in metastatic breast cancer. Monoclonal antibodies and tyrosine kinase inhibitors

Plasma YKL-40 is associated with prognosis in patients with metastatic pancreatic cancer receiving immune checkpoint inhibitors in combination with radiotherapy

Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: A systematic review of incidence, manifestations and predisposing factors

Pre-existing TGF-β-specific T-cell immunity in patients with pancreatic cancer predicts survival after checkpoint inhibitors combined with radiotherapy

Development and validation of circulating protein signatures as diagnostic biomarkers for biliary tract cancer

Gemcitabine Plus Docetaxel Versus Docetaxel in Patients With Predominantly Human Epidermal Growth Factor Receptor 2–Negative Locally Advanced or Metastatic Breast Cancer: A Randomized, Phase III Study by the Danish Breast Cancer Cooperative Group

Effects of a 12-Week Multimodal Exercise Intervention Among Older Patients with Advanced Cancer: Results from a Randomized Controlled Trial

TIMP-1 and responsiveness to gemcitabine in advanced breast cancer; results from a randomized phase III trial from the Danish breast cancer cooperative group

Metabolomic NMR Fingerprinting to Identify and Predict Survival of Patients with Metastatic Colorectal Cancer

Adjuvant Cyclophosphamide and Docetaxel With or Without Epirubicin for Early TOP2A-Normal Breast Cancer: DBCG 07-READ, an Open-Label, Phase III, Randomized Trial

Circulating Protein Biomarkers for Use in Pancreatic Ductal Adenocarcinoma Identification

Physical decline, falls, and hospitalization among vulnerable older patients in the trajectory of colorectal cancer treatment

Nurse-Led Individualized Follow-Up Versus Regular Physician-Led Visits After Early Breast Cancer (MyHealth): A Phase III Randomized, Controlled Trial

Prognostic Value of Pretreatment Plasma C-Reactive Protein in Patients with Early-Stage Breast Cancer

A systematic review on topoisomerase 1 inhibition in the treatment of metastatic breast cancer

Cetuximab plus irinotecan administered biweekly with reduced infusion time to heavily pretreated patients with metastatic colorectal cancer and related RAS and BRAF mutation status

Therapy with pembrolizumab in treatment‐naïve patients with nonmetastatic, mismatch repair deficient colorectal cancer

Myocardial Ischemia Induced by 5‐Fluorouracil: A Prospective Electrocardiographic and Cardiac Biomarker Study

Antitumour immunity invoked by hepatic arterial infusion of first‐line oxaliplatin predicts durable colorectal cancer control after liver metastasis ablation: 8–12 years of follow‐up

Tissue-Doppler Assessment of Cardiac Left Ventricular Function during Short-Term Adjuvant Epirubicin Therapy for Breast Cancer

Similar Efficacy for Ovarian Ablation Compared With Cyclophosphamide, Methotrexate, and Fluorouracil: From a Randomized Comparison of Premenopausal Patients With Node-Positive, Hormone Receptor–Positive Breast Cancer

Cancer patients, physicians, and nurses differ in their attitudes toward the decisional role in do-not-resuscitate decision-making

Preoperative plasma vitamin D in patients with localized colorectal cancer: Age-dependent association with inflammation, postoperative complications, and survival

Suchergebnisse filtern